.Attribute Medicine, Released online: 03 September 2024 doi:10.1038/ s41591-024-03223-zThis Point of view requires incorporation of people with MASLD and also measurement of liver results in cardio-- renal-- metabolic tests, when information propose mechanistically probable perks and also medical protection-- as well as describes points to consider for trial design as well as regulatory approval.